SEC Form 4 · accession 0001231919-26-000638
Parabilis Medicines, Inc. · PBLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
RA Capital Healthcare Fund LP
Director · 10% Owner
RA CAPITAL MANAGEMENT, L.P.
Director · 10% Owner
Peter Kolchinsky
Director · 10% Owner
Rajeev M. Shah
Director · 10% Owner
RA Capital Nexus Fund III, L.P.
Director
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 6:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001657677
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Voting Common StockF1,F2,F3,F4 | Jun 11, 2026 | C | 6,556,740 | — | A | 6,556,740 | I | See footnotes |
| Voting Common StockF1,F2,F3,F5 | Jun 11, 2026 | C | 1,187,881 | — | A | 1,187,881 | I | See footnotes |
| Voting Common StockF3,F4 | Jun 11, 2026 | P | 19,728,353 | $20.00 | A | 26,285,093 | I | See footnotes |
| Voting Common StockF3,F5 | Jun 11, 2026 | P | 1,460,397 | $20.00 | A | 2,648,278 | I | See footnotes |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series E Preferred StockF1,F3,F4 | — | Jun 11, 2026 | C | 642,250 | D | — | — | Voting Common Stock | 419,006 | 0 | I |
| Series E Preferred StockF1,F3,F5 | — | Jun 11, 2026 | C | 160,562 | D | — | — | Voting Common Stock | 104,751 | 0 | I |
| Series F Preferred StockF2,F3,F4 | — | Jun 11, 2026 | C | 9,445,363 | D | — | — | Voting Common Stock | 6,137,734 | 0 | I |
| Series F Preferred StockF2,F3,F5 | — | Jun 11, 2026 | C | 1,666,829 | D | — | — | Voting Common Stock | 1,083,130 | 0 | I |
Explanation of responses
- F1Each share of Series E Preferred Stock automatically converted into Voting Common Stock on a 1 to 0.6524 basis immediately prior to the closing of the IPO and without payment of consideration. The Series E Preferred Stock has no expiration date.
- F2Each share of Series F Preferred Stock automatically converted into shares of Voting Common Stock on a 1 to 0.6498 basis immediately prior to the closing of the IPO and without payment of consideration. The Series F Preferred Stock has no expiration date.
- F3RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
- F4Held directly by the Fund.
- F5Held directly by Nexus Fund III.
Remarks
Dr. Jake Simson, a Partner of the Adviser, serves on the Issuer's board of directors.